Pancreatic cancer is likely to become the second most frequent cause of cancer-associated
mortality within the next decade. Surgical resection with adjuvant systemic chemotherapy …

Pancreatic cancer is one of the most lethal solid organ tumors. Due to the rising incidence,
late diagnosis, and limited treatment options, it is expected to be the second leading cause …

Objective: To use the concept of benchmarking to establish robust and standardized
outcome references after pancreatico-duodenectomy (PD). Background: Best achievable …

Objective Resection can potentially cure resectable pancreatic cancer (PaC) and
significantly prolong survival in some patients. This large-scale international study aimed to …

Objective: To depict and analyze learning curves for open, laparoscopic, and robotic
pancreatoduodenectomy (PD) and distal pancreatectomy (DP). Background: Formal training …

Objective: To compare short-term and oncologic outcomes of patients with cancer who
underwent open pancreaticoduodenectomy (OPD) versus minimally invasive …

Methods In this retrospective, descriptive analysis, nationwide hospital billing data based on
diagnosis-related groups (DRG) over the period 2009–2015 were studied to determine the …

Objectives To explore the existence and strength of a relationship between hospital volume
and mortality, to estimate minimum volume thresholds and to assess the potential benefit of …

Diese Leitlinie umfasst erstmals die akute wie auch die chronische Pankreatitis, um so
Übergänge der beiden ehemals getrennt wahrgenommenen Krankheitsbilder gemäß einem …

Objective: The aim of this study was to pool data from randomized controlled trials (RCT)
limited to resectable pancreatic ductal adenocarcinoma (PDAC) to determine whether a …